STRATA Skin Sciences, Inc. (SSKN)
USD 2.59
(-1.19%)
USD 2.59
(-1.19%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.83 Million USD | -95.17% |
| 2022 | -5.54 Million USD | -105.06% |
| 2021 | -2.7 Million USD | 38.67% |
| 2020 | -4.41 Million USD | -16.41% |
| 2019 | -3.79 Million USD | 6.03% |
| 2018 | -4.03 Million USD | 81.25% |
| 2017 | -21.51 Million USD | -545.1% |
| 2016 | -3.33 Million USD | 88.05% |
| 2015 | -27.9 Million USD | -74.08% |
| 2014 | -16.03 Million USD | 38.21% |
| 2013 | -25.94 Million USD | -14.44% |
| 2012 | -22.67 Million USD | -11.23% |
| 2011 | -20.38 Million USD | -2.32% |
| 2010 | -19.92 Million USD | -7.96% |
| 2009 | -18.45 Million USD | -4.82% |
| 2008 | -17.6 Million USD | -47.48% |
| 2007 | -11.93 Million USD | -12.71% |
| 2006 | -10.59 Million USD | -57.46% |
| 2005 | -6.72 Million USD | -85.85% |
| 2004 | -3.61 Million USD | -85.6% |
| 2003 | -1.95 Million USD | -70.9% |
| 2002 | -1.14 Million USD | 60.22% |
| 2001 | -2.86 Million USD | -25.79% |
| 2000 | -2.28 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.36 Million USD | 11.23% |
| 2024 Q2 | -99 Thousand USD | 97.06% |
| 2023 FY | -10.83 Million USD | -95.17% |
| 2023 Q1 | -2.83 Million USD | -1671.88% |
| 2023 Q3 | -1.05 Million USD | 66.55% |
| 2023 Q4 | -3.79 Million USD | -260.3% |
| 2023 Q2 | -3.14 Million USD | -11.04% |
| 2022 Q1 | -2.5 Million USD | -194.7% |
| 2022 FY | -5.54 Million USD | -105.06% |
| 2022 Q4 | -160 Thousand USD | 83.92% |
| 2022 Q3 | -995 Thousand USD | 47.41% |
| 2022 Q2 | -1.89 Million USD | 24.38% |
| 2021 Q3 | -521 Thousand USD | -148.15% |
| 2021 Q2 | 1.08 Million USD | 144.75% |
| 2021 Q1 | -2.41 Million USD | -445.82% |
| 2021 FY | -2.7 Million USD | 38.67% |
| 2021 Q4 | -849 Thousand USD | -62.96% |
| 2020 Q2 | -1.68 Million USD | -62.32% |
| 2020 Q1 | -1.03 Million USD | -100.97% |
| 2020 Q3 | -1.25 Million USD | 25.36% |
| 2020 FY | -4.41 Million USD | -16.41% |
| 2020 Q4 | -443 Thousand USD | 64.67% |
| 2019 Q2 | -1.08 Million USD | 18.83% |
| 2019 Q4 | -515 Thousand USD | 40.12% |
| 2019 Q1 | -1.33 Million USD | -567.72% |
| 2019 Q3 | -860 Thousand USD | 20.52% |
| 2019 FY | -3.79 Million USD | 6.03% |
| 2018 Q4 | 285 Thousand USD | 146.88% |
| 2018 Q2 | -1.62 Million USD | 21.72% |
| 2018 Q1 | -2.08 Million USD | 52.74% |
| 2018 FY | -4.03 Million USD | 81.25% |
| 2018 Q3 | -608 Thousand USD | 62.68% |
| 2017 Q3 | -13.67 Million USD | -1034.52% |
| 2017 Q2 | -1.2 Million USD | 46.09% |
| 2017 Q1 | -2.23 Million USD | -151.97% |
| 2017 FY | -21.51 Million USD | -545.1% |
| 2017 Q4 | -4.4 Million USD | 67.79% |
| 2016 Q1 | -1.43 Million USD | -142.33% |
| 2016 Q4 | -887 Thousand USD | 41.22% |
| 2016 Q3 | -1.5 Million USD | -403.01% |
| 2016 FY | -3.33 Million USD | 88.05% |
| 2016 Q2 | 498 Thousand USD | 134.66% |
| 2015 Q4 | -593 Thousand USD | 95.14% |
| 2015 Q1 | -7.27 Million USD | -13.79% |
| 2015 FY | -27.9 Million USD | -74.08% |
| 2015 Q3 | -12.19 Million USD | -55.42% |
| 2015 Q2 | -7.84 Million USD | -7.91% |
| 2014 Q4 | -6.39 Million USD | -179.33% |
| 2014 FY | -16.03 Million USD | 38.21% |
| 2014 Q3 | -2.28 Million USD | -464.91% |
| 2014 Q2 | 627 Thousand USD | 107.86% |
| 2014 Q1 | -7.98 Million USD | -73.11% |
| 2013 Q1 | -6.51 Million USD | -7.12% |
| 2013 FY | -25.94 Million USD | -14.44% |
| 2013 Q4 | -4.61 Million USD | 37.74% |
| 2013 Q3 | -7.4 Million USD | 0.23% |
| 2013 Q2 | -7.42 Million USD | -13.98% |
| 2012 Q1 | -5.75 Million USD | -27.21% |
| 2012 FY | -22.67 Million USD | -11.23% |
| 2012 Q4 | -6.07 Million USD | -13.48% |
| 2012 Q3 | -5.35 Million USD | 2.32% |
| 2012 Q2 | -5.48 Million USD | 4.67% |
| 2011 FY | -20.38 Million USD | -2.32% |
| 2011 Q1 | -4.94 Million USD | 7.19% |
| 2011 Q4 | -4.52 Million USD | 25.99% |
| 2011 Q3 | -6.11 Million USD | -27.05% |
| 2011 Q2 | -4.8 Million USD | 2.68% |
| 2010 Q4 | -5.32 Million USD | -7.46% |
| 2010 Q1 | -5.05 Million USD | 9.48% |
| 2010 FY | -19.92 Million USD | -7.96% |
| 2010 Q2 | -4.59 Million USD | 9.11% |
| 2010 Q3 | -4.95 Million USD | -7.92% |
| 2009 Q4 | -5.58 Million USD | -10.55% |
| 2009 Q2 | -3.83 Million USD | 3.87% |
| 2009 Q1 | -3.98 Million USD | 4.49% |
| 2009 FY | -18.45 Million USD | -4.82% |
| 2009 Q3 | -5.04 Million USD | -31.62% |
| 2008 Q4 | -4.17 Million USD | 0.55% |
| 2008 Q3 | -4.19 Million USD | 15.18% |
| 2008 Q2 | -4.95 Million USD | -15.77% |
| 2008 Q1 | -4.27 Million USD | -36.28% |
| 2008 FY | -17.6 Million USD | -47.48% |
| 2007 Q4 | -3.13 Million USD | -15.84% |
| 2007 Q2 | -3.09 Million USD | -3.45% |
| 2007 FY | -11.93 Million USD | -12.71% |
| 2007 Q3 | -2.7 Million USD | 12.52% |
| 2007 Q1 | -2.99 Million USD | -27.4% |
| 2006 Q1 | -2.88 Million USD | -16.74% |
| 2006 Q2 | -2.92 Million USD | -1.35% |
| 2006 Q3 | -2.42 Million USD | 17.16% |
| 2006 Q4 | -2.34 Million USD | 3.12% |
| 2006 FY | -10.59 Million USD | -57.46% |
| 2005 Q2 | -1.4 Million USD | -13.27% |
| 2005 Q4 | -2.47 Million USD | -71.52% |
| 2005 Q3 | -1.44 Million USD | -2.72% |
| 2005 FY | -6.72 Million USD | -85.85% |
| 2005 Q1 | -1.24 Million USD | 8.64% |
| 2004 Q3 | -746.08 Thousand USD | 0.0% |
| 2004 Q4 | -1.35 Million USD | -81.92% |
| 2004 FY | -3.61 Million USD | -85.6% |
| 2003 FY | -1.95 Million USD | -70.9% |
| 2002 FY | -1.14 Million USD | 60.22% |
| 2001 FY | -2.86 Million USD | -25.79% |
| 2000 FY | -2.28 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 82.424% |
| BrainsWay Ltd. | -4.19 Million USD | -158.041% |
| Cerus Corporation | -37.48 Million USD | 71.112% |
| Envoy Medical, Inc. | -29.9 Million USD | 63.789% |
| electroCore, Inc. | -18.83 Million USD | 42.498% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -22.373% |
| IceCure Medical Ltd | -14.65 Million USD | 26.085% |
| Inogen, Inc. | -102.44 Million USD | 89.429% |
| OrthoPediatrics Corp. | -20.97 Million USD | 48.365% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 79.436% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 21.209% |
| MaxCyte, Inc. | -37.92 Million USD | 71.442% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 8.681% |
| Nexalin Technology, Inc. | -4.64 Million USD | -132.968% |
| Orthofix Medical Inc. | -151.39 Million USD | 92.847% |
| PAVmed Inc | -64.17 Million USD | 83.124% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 79.358% |
| RxSight, Inc. | -48.6 Million USD | 77.72% |
| Sight Sciences, Inc. | -55.54 Million USD | 80.503% |
| SI-BONE, Inc. | -43.33 Million USD | 75.009% |
| TELA Bio, Inc. | -46.66 Million USD | 76.792% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 78.133% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 20.268% |
| Acutus Medical, Inc. | -81.66 Million USD | 86.738% |
| Talis Biomedical Corporation | -62 Million USD | 82.534% |
| Spectral AI, Inc. | -20.85 Million USD | 48.068% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 82.18% |
| CVRx, Inc. | -41.19 Million USD | 73.713% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1791.669% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 1.144% |
| Bioventus Inc. | -156.23 Million USD | 93.068% |
| Venus Concept Inc. | -37.25 Million USD | 70.926% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 81.656% |
| LivaNova PLC | 17.54 Million USD | 161.723% |
| 908 Devices Inc. | -36.39 Million USD | 70.246% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 94.197% |
| Nemaura Medical Inc. | -14.14 Million USD | 23.429% |
| NeuroPace, Inc. | -32.95 Million USD | 67.138% |
| LENSAR, Inc. | -14.38 Million USD | 24.703% |
| Apyx Medical Corporation | -18.71 Million USD | 42.126% |
| Cutera, Inc. | -162.83 Million USD | 93.349% |
| BioSig Technologies, Inc. | -29.04 Million USD | 62.708% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 86.899% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 50.971% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 115.987% |
| Axonics, Inc. | -6.08 Million USD | -77.891% |
| Outset Medical, Inc. | -172.79 Million USD | 93.733% |
| IRIDEX Corporation | -9.57 Million USD | -13.166% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 89.773% |
| IRadimed Corporation | 17.19 Million USD | 162.992% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -31.368% |
| INVO Bioscience, Inc. | -8.03 Million USD | -34.792% |
| Telesis Bio, Inc. | -47.72 Million USD | 77.307% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 205.731% |
| Varex Imaging Corporation | -47.7 Million USD | 77.296% |
| Quipt Home Medical Corp. | -2.78 Million USD | -289.009% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 4.04% |
| Pulmonx Corporation | -60.84 Million USD | 82.2% |
| Dynatronics Corporation | -2.69 Million USD | -301.45% |
| Modular Medical, Inc. | -17.47 Million USD | 38.008% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 4.892% |
| Semler Scientific, Inc. | 20.58 Million USD | 152.616% |
| InMode Ltd. | 197.91 Million USD | 105.472% |
| Bruker Corporation | 427.2 Million USD | 102.535% |
| Cytosorbents Corporation | -28.5 Million USD | 62.01% |
| DexCom, Inc. | 541.5 Million USD | 102.0% |
| Align Technology, Inc. | 445.05 Million USD | 102.433% |
| Viveve Medical, Inc. | -22.02 Million USD | 50.833% |
| ZimVie Inc. | -393.28 Million USD | 97.246% |
| Movano Inc. | -29.28 Million USD | 63.016% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 10.85% |
| Nexalin Technology, Inc. | -4.64 Million USD | -132.968% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1791.669% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 95.135% |
| Profound Medical Corp. | -28.56 Million USD | 62.092% |
| Insulet Corporation | 206.3 Million USD | 105.25% |
| enVVeno Medical Corporation | -23.51 Million USD | 53.946% |
| Surmodics, Inc. | -11.54 Million USD | 6.169% |
| iCAD, Inc. | -4.84 Million USD | -123.437% |
| Nuwellis, Inc. | -20.2 Million USD | 46.41% |
| Biotricity, Inc. | -14.09 Million USD | 23.16% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 91.224% |
| Aethlon Medical, Inc. | -12.2 Million USD | 11.289% |
| InspireMD, Inc. | -19.91 Million USD | 45.622% |
| PAVmed Inc. | -64.17 Million USD | 83.124% |
| BIOLASE, Inc. | -20.63 Million USD | 47.509% |
| Beyond Air, Inc. | -60.24 Million USD | 82.023% |
| FONAR Corporation | 10.56 Million USD | 202.485% |
| AxoGen, Inc. | -21.71 Million USD | 50.129% |
| Vivani Medical, Inc. | -25.65 Million USD | 57.781% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 137.98% |
| Inari Medical, Inc. | -1.63 Million USD | -561.98% |
| UFP Technologies, Inc. | 44.92 Million USD | 124.107% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -111.015% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -63.962% |
| Tenon Medical, Inc. | -15.58 Million USD | 30.492% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 29.794% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 69.349% |
| AdaptHealth Corp. | -678.89 Million USD | 98.405% |
| Sintx Technologies, Inc. | -8.25 Million USD | -31.13% |
| NanoVibronix, Inc. | -3.71 Million USD | -191.835% |
| Quanterix Corporation | -32.33 Million USD | 66.506% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 4.04% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 2332.99% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.469% |
| TransMedics Group, Inc. | -25.02 Million USD | 56.728% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 51.069% |
| NeuroMetrix, Inc. | -6.52 Million USD | -65.863% |
| Hyperfine, Inc. | -44.23 Million USD | 75.519% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 86.204% |
| Biomerica, Inc. | -5.97 Million USD | -81.164% |
| Bone Biologics Corporation | -8.94 Million USD | -21.023% |
| AVITA Medical, Inc. | -39.16 Million USD | 72.35% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -8.802% |
| Silk Road Medical, Inc | -55.74 Million USD | 80.572% |